Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONICA haptoglobin for prevention of hemolytic AKI in cardiac surgery
jRCT1031190038Recruiting
- Sponsor
- Department of Anesthesiology
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of haptoglobin in acute kidney failure (AKF) and Cardiac valve disease (VHD) (2 arms), sponsored by Department of Anesthesiology. Primary endpoint: Acute kidney failure occurrence. Started Jun 2019; status: recruiting.
02
Drugs
haptoglobin
03
Conditions
acute kidney failure (AKF)Cardiac valve disease (VHD)
Beyond the preview
Go deeper on jRCT1031190038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031190038.